ipamorelin mechanism of action growth hormone secretagogue secretagogues: history, action, and clinical development - Ishida - 2020 - JCSM Rapid Communications CJC 1295
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Anderson M
[DOI] [PubMed] [Google Scholar] 15.Lee S, Kim E, Moon CE, Park C, Lim JW, Baek M, Shin MK, Ki J, Cho H, Ji YW, et al
Nrf2/ARE, Nuclear factor erythroid 2-related factor 2/Antioxidant response element
clone vpg9, Bio-Rad Laboratories Inc., Cat No
Stack Snapshot: Semaglutide + CJC-1295 + Ipamorelin Primary mechanism: GLP-1 appetite suppression + GH-driven lipolysis Best for: Significant fat loss with muscle preservation Research dosing (subcutaneous): Semaglutide 0.251mg/week
P = 0.0015), but not the interpulse GH concentrations (R = 0.25
